Sage Therapeutics (SAGE) Earnings Date, Estimates & Call Transcripts $5.27 0.00 (0.00%) (As of 09:46 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Sage Therapeutics Latest Earnings SummaryActual EPS (Oct. 29) -$1.53 Missed By -$0.01 Consensus EPS (Oct. 29) -$1.52 Sage Therapeutics posted Q3 2024 earnings on October 29, 2024, reporting an EPS of -$1.53, which missed analysts' consensus estimates of -$1.52 by $0.01. Quarterly revenue rose 337.1% year-over-year to $11.87 million, above the consensus estimate of $10.80 million. With a trailing EPS of -$5.58, Sage Therapeutics' earnings are expected to grow next year, from ($6.53) to ($3.90) per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by Get Sage Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sage Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSAGE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SAGE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Sage Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244-$1.92-$1.44-$1.70Q2 20244-$1.81-$1.45-$1.68Q3 20244-$1.65-$1.39-$1.52Q4 20244-$2.03-$1.27-$1.66FY 202416-$7.41-$5.55-$6.56Q1 20253-$1.64-$1.31-$1.50Q2 20253-$1.56-$1.16-$1.34Q3 20253-$1.55-$0.99-$1.24Q4 20253-$1.54-$0.95-$1.22FY 202512($6.29)($4.41)($5.30) Sage Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails10/29/2024Q3 2024-$1.52-$1.53 -$0.01-$1.53$10.80M$11.87M7/31/2024Q2 2024-$1.68-$1.70 -$0.02-$1.70$8.85M$8.65M4/25/2024Q1 2024-$1.63-$1.80 -$0.17-$1.80$5.26M$7.90M2/14/2024Q4 2023-$1.28-$0.55+$0.73-$0.55$60.15M$77.97M11/7/2023Q3 2023-$2.64-$2.81 -$0.17-$2.25$9.02M$2.72M8/7/2023Q2 2023-$2.55-$2.68 -$0.13-$2.68$2.94M$2.47M Get the Latest News and Ratings for SAGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/2/2023Q1 2023-$2.50-$2.46+$0.04-$2.46$2.28M$3.30M2/16/2023Q4 2022-$2.37-$2.47 -$0.10-$2.47$1.94M$2.87M Sage Therapeutics Earnings - Frequently Asked Questions When did Sage Therapeutics announce their last quarterly earnings? Sage Therapeutics (NASDAQ:SAGE) last announced its quarterly earning data on Tuesday, October 29, 2024. Learn more on SAGE's earnings history. Did Sage Therapeutics beat their earnings estimates last quarter? In the previous quarter, Sage Therapeutics (NASDAQ:SAGE) missed the analysts' consensus estimate of ($1.52) by $0.01 with a reported earnings per share (EPS) of ($1.53). Learn more on analysts' earnings estimate vs. SAGE's actual earnings. How can I listen to Sage Therapeutics's earnings conference call? The conference call for Sage Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Sage Therapeutics's conference call transcript? The conference call transcript for Sage Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Sage Therapeutics generate each year? Sage Therapeutics (NASDAQ:SAGE) has a recorded annual revenue of $106.40 million. How much profit does Sage Therapeutics generate each year? Sage Therapeutics (NASDAQ:SAGE) has a recorded net income of -$541.49 million. SAGE has generated -$5.58 earnings per share over the last four quarters. What is Sage Therapeutics's EPS forecast for next year? Sage Therapeutics's earnings are expected to grow from ($6.53) per share to ($3.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies Ardelyx Earnings Spyre Therapeutics Earnings Calliditas Therapeutics AB (publ) Earnings ARS Pharmaceuticals Earnings ANI Pharmaceuticals Earnings Syndax Pharmaceuticals Earnings Rocket Pharmaceuticals Earnings Bicycle Therapeutics Earnings Avadel Pharmaceuticals Earnings Collegium Pharmaceutical Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings How to piss off your liberal friends… and profit from it (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now This page (NASDAQ:SAGE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sage Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sage Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SAGE Stock Alerts